Cancer Immunotherapy Utilizing A Novel Receptor For Programmed Cell Death-1 Ligand 2
Funder
National Health and Medical Research Council
Funding Amount
$577,857.00
Summary
Immuno-modulators utilize the patient’s own immune system to eliminate or slow the growth of cancerous cells. We have identified a novel immuno-modulator which could be a significant player in immune-modulation therapy for the treatment of cancer. We will use the development grant to develop a product which has significant potential to be the next generation treatment for cancer.
Development Of An Effective Therapy For Cheyne-Stokes Breathing In Heart Failure.
Funder
National Health and Medical Research Council
Funding Amount
$604,030.00
Summary
During sleep, patients with heart failure often exhibit a cyclic pattern of breathing in which a period of regular breathing alternates with a period when breathing ceases. This breathing pattern is associated with increased mortality and reduced quality of life but to date no effective treatment for it exists. We have developed a method to calculate an exact level of carbon dioxide to stabilise breathing in each individual, offering the prospect of a better night’s sleep and a longer life.